Delivery Order SPE2DB20D3101-SPE2DB23FRJF6
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product. The contract has a firm fixed price of $1,138.25 and a completion date of July 24, 2025. It is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a $2,360.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with a period of performance through December 10, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rhogam Ultra-Filtered Plus Syringes. The contract has a ceiling value of $2,360.40 and a performance period that runs through July 3, 2024. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,969.36 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with performance to be completed by July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026. No set-aside designation was applied to this...
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of RHOGAM ULTRA-FILTERED PLUS syringes. The contract was awarded by the Defense Logistics Agency (DLA) and is a Delivery Order with a Firm Fixed Price of $1,652.28 and a Period of Performance ending on November 1, 2024. The contract does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain to provide a wide range...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,906.60 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order, issued on November 20, 2025, represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,969.36 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with delivery to be completed by August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued on August 7, 2025. The product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $2,060.62 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes on October 21, 2025, with completion scheduled for November 12, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. RhoGAM is an immunoglobulin...
- This contract award, valued at $1,387.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and covers the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product. The award has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $3,824.00 delivery order by the Defense Logistics Agency on September 11, 2025, for the supply of Rhophylac 300 micrograms per 2 milliliter syringes. This is a competitively awarded, non-set-aside contract utilizing firm fixed pricing, with an ultimate completion date of October 2, 2025. The award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRJF6Delivery Order
This is a contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rhogam Ultra-Filtered Plus Syrs. The contract is a delivery order with a firm fixed price of $1,392.60 and an ultimate completion date of May 8, 2023. It is not associated with any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 Indefinite Delivery Contract with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 4/17/23 |